AVITA Medical, Inc.·4

Jun 1, 4:37 PM ET

Vance Cary Guy 4

4 · AVITA Medical, Inc. · Filed Jun 1, 2026

Research Summary

AI-generated summary of this filing

Updated

AVITA Medical CEO Vance Guy Buys 5,000 Shares via ESPP

What Happened

  • Vance Cary Guy, President & CEO and Director of AVITA Medical (RCEL), acquired 5,000 shares on May 29, 2026 at $3.05 per share, for a total of $15,258. The acquisition was made under AVITA’s Employee Share Purchase Plan (ESPP), a purchase rather than a sale.

Key Details

  • Transaction date and price: 2026-05-29 — 5,000 shares at $3.05 each (total $15,258).
  • Filing: SEC Form 4 filed June 1, 2026 (Accession 0001193125-26-251586; Period of Report 2026-05-29).
  • Shares owned after transaction: not stated in the provided excerpt; the filing notes that reported ownership figures include unvested RSUs (see footnote F2).
  • Notable footnote(s):
    • F1: Shares were purchased under the ESPP for the offering period 12/01/2025–05/31/2026 and were acquired at a price equal to 85% of the closing price on 12/01/2025. The transactions were exempt under Rule 16b-3(d) and 16b-3(c).
    • F2: Reported ownership includes unvested restricted stock units (RSUs).
  • Timeliness: Form 4 filed on June 1, 2026 as indicated in the filing (no late-filing flag provided in the excerpt).

Context

  • ESPP purchases are routine employee benefit transactions: eligible employees contribute payroll amounts and buy shares at a discounted price (here, 85% of the Dec 1, 2025 closing price). Such purchases show participation in the company plan but do not by themselves prove insider sentiment about the stock.
  • Transaction value is modest (~$15.3k) relative to typical executive trades; this was an ESPP acquisition, not an option exercise or sale.

Insider Transaction Report

Form 4
Period: 2026-05-29
Vance Cary Guy
DirectorPresident and CEO
Transactions
  • Award

    Common Stock

    [F1][F2]
    2026-05-29$3.05/sh+5,000$15,25840,771 total
Footnotes (2)
  • [F1]These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on December 1, 2025 and ended on May 31, 2026 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on December 1, 2025 (the purchase date of the offering period).
  • [F2]Includes unvested RSUs.
Signature
/s/ Nicole Kelsey, by power of attorney|2026-06-01

Documents

1 file
  • 4
    ownership.xmlPrimary

    4